MMP2 and familial dilated cardiomyopathy: Although several factors had been hypothesized by the authors to justify the variability of MMP-2 plasma levels in response to hyperglycaemia [42], we suppose that these differences might simply reflect the evolution of the remodelling process during DCM that, in the early stages, is characterized by MMP-2 down-regulation.